about
Genes other than BRCA1 and BRCA2 involved in breast cancer susceptibilityPhenotypic alterations in breast cancer cells overexpressing the nuclear receptor co-activator AIB1Identification of a novel breast-cancer-anti-estrogen-resistance (BCAR2) locus by cell-fusion-mediated gene transfer in human breast-cancer cellsEstrogen withdrawal-induced NF-kappaB activity and bcl-3 expression in breast cancer cells: roles in growth and hormone independenceEstrogen regulates the expression of several different estrogen receptor mRNA isoforms in rat pituitary.A novel 80 kDa human estrogen receptor containing a duplication of exons 6 and 7CARM1 is an important determinant of ERα-dependent breast cancer cell differentiation and proliferation in breast cancer cells.Controversies surrounding androgen deprivation for prostate cancer.Frequency of oestrogen and progesterone receptor positivity by immunohistochemical analysis in 7016 breast carcinomas: correlation with patient age, assay sensitivity, threshold value, and mammographic screening.Differential CARM1 Isoform Expression in Subcellular Compartments and among Malignant and Benign Breast Tumors.Expression of estrogen receptor variant messenger RNAs and determination of estrogen receptor status in human breast cancerAssociation between the estrogen receptor alpha A908G mutation and outcomes in invasive breast cancer.Differential expression of estrogen, progesterone, and epidermal growth factor receptors in normal, benign, and malignant human breast tissues using dual staining immunohistochemistry.Activation of the unliganded estrogen receptor by EGF involves the MAP kinase pathway and direct phosphorylationDetection of an oestrogen receptor-like protein in human meningiomas by band shift assay using a synthetic oestrogen responsive element (ERE)cDNA transfection followed by the isolation of a MCF-7 breast cell line resistant to tamoxifen in vitro and in vivo.Absence of the K303R estrogen receptor α mutation in breast cancer patients exhibiting different responses to aromatase inhibitor anastrozole neoadjuvant treatment.Presence of exon 5-deleted oestrogen receptor in human breast cancer: functional analysis and clinical significance.Comparison of a new microplate oestrogen receptor (ER) enzyme immunoassay with other ER detection methods.Estrogen modulates metabolic pathway adaptation to available glucose in breast cancer cellsTranscriptional regulation of estrogen receptor in breast carcinomasConstitutive activation of NF-kappaB during progression of breast cancer to hormone-independent growth.Responses in the brain of estrogen receptor alpha-disrupted miceAltered expression of exon 6 deleted progesterone receptor variant mRNA between normal human breast and breast tumour tissues.Absence of progesterone receptor associated with secondary breast cancer in postmenopausal women.DNA methylation analysis at distal and proximal promoter regions of the oestrogen receptor gene in breast cancers.Alteration of reproductive function but not prenatal sexual development after insertional disruption of the mouse estrogen receptor gene.Status of HER-2/neu receptors and Ki-67 in breast cancer of Indian womenEstrogen receptor splice variants as a potential source of false-positive estrogen receptor status in breast cancer diagnostics.Androgen receptor gene mutations in human prostate cancer.Variability in hormone and growth factor receptor expression in primary versus recurrent, metastatic, and post-neoadjuvant breast carcinoma.Analysis of mechanisms that determine dominant negative estrogen receptor effectiveness.Loss of co-ordinate expression of progesterone receptors A and B is an early event in breast carcinogenesis.Natural trans-spliced mRNAs are generated from the human estrogen receptor-alpha (hER alpha) gene.Expression of the estrogen receptor-associated immunophilins, cyclophilin 40 and FKBP52, in breast cancer.Oestrogen receptor variants and mutations in human breast cancer.Effects of 12-O-tetradecanoylphorbol-13-acetate on estrogen receptor activity in MCF-7 cells.Mechanisms of tamoxifen resistance in the treatment of advanced breast cancer.William L. McGuire Memorial Lecture. Antiestrogens: mechanisms of action and resistance in breast cancer.Transcription factors in normal and neoplastic pituitary tissues.
P2860
Q24679438-519913B8-0898-40AA-B8A9-6E8AE323AF90Q24802051-EBF4A6C7-AAFE-4ABA-93F8-637338099970Q28246373-267ECDAF-4A30-42C9-8BCA-A29A4C1621E1Q28396413-8E1759CB-3237-44A9-9B30-36C6FC3E72C2Q30453964-A59C6E42-86CA-43F5-A3B8-BF4F92C02504Q34591772-04398DAE-0B29-4729-881C-1391A5DC80A8Q34794245-B723864F-8A4F-4C31-A434-8DA97BD0F122Q34849222-64B48C7A-2FE8-4CF6-A785-DC002B2D179AQ35396974-C02F2B2B-1879-4C0B-B8F9-E0B90EEFE67DQ35673016-76536735-CCBC-462D-9CE5-45D6E46FDC27Q35764377-F3168152-534B-43D1-9FD9-82F7C3373713Q35794355-8F2E08AA-00D6-4F0F-923E-1213E5EC685EQ35834174-91BD7AD6-58C0-4FE0-8DA1-6579D6C2D27DQ35849279-5758EAB5-24F2-4D38-9D78-7E66E3B3BE3BQ35977228-04945E5A-231B-4ED5-B503-83E300C7E995Q35977569-84AB6B3D-EF7C-4B2B-97FC-093D14C2DF08Q36246651-6FB99024-4E6D-4421-B203-7910316AF604Q36420212-5E20495D-596A-43B4-8FAD-06078AA28F25Q36430956-8D83D379-D310-4C75-A94B-1AEBDCD95170Q36454569-BA6C91A5-169A-4190-8DD7-7345550AA4E7Q36550557-2965CE2E-3EBC-4C76-8ADD-F82BA8F02CE5Q36569036-63395F74-393B-4C94-891F-4AF7FAA66944Q36604561-89482678-8768-40EA-BCDD-37EF8BB69B8AQ36617807-FD47810E-076D-4B13-9A52-1C369FC250ECQ36619003-D94C98AD-862E-4C51-94A1-9495892E8710Q36640883-B0D4C1F9-7244-46F0-BAC3-2944318EE68DQ36692660-77CC6B7C-E1E2-406D-96E0-FCDD29CCABB9Q36855747-5CB41528-1EA8-4A15-9745-C3B0E0A0801BQ37094009-B8F968AD-5DC2-4C4A-AB4A-F2D151CAA24CQ37104443-101485B8-E608-412A-AAF6-F65B9BB273B6Q38000948-FC22FA62-0489-4760-8D0D-7D675F536609Q38287686-FC872420-CF60-48F2-B896-B8AA5EEF96E2Q38456582-E51CC207-9B99-49A3-854E-F8CA9E34FCB2Q40732034-5A269441-0D61-4373-80E6-8EF56B8E45A5Q40893689-2BEA69E8-0D9F-4031-8D2B-BA573B52EC31Q41106289-7B163415-30FD-42E7-8B76-5C7AA499DF4CQ41281540-1A603971-40E4-40B0-A426-1D46B7DCFDE3Q41463841-E57BF2F4-3A11-48B9-960B-1D5CA9A66370Q41481880-255B9258-7CB9-4B15-980B-6A91BDA9E9D2Q41636025-3189A7A6-7F8F-4CDF-AC56-47A95F39FA69
P2860
description
1991 nî lūn-bûn
@nan
1991年の論文
@ja
1991年論文
@yue
1991年論文
@zh-hant
1991年論文
@zh-hk
1991年論文
@zh-mo
1991年論文
@zh-tw
1991年论文
@wuu
1991年论文
@zh
1991年论文
@zh-cn
name
Estrogen receptor variants in clinical breast cancer.
@en
type
label
Estrogen receptor variants in clinical breast cancer.
@en
prefLabel
Estrogen receptor variants in clinical breast cancer.
@en
P2093
P356
P1476
Estrogen receptor variants in clinical breast cancer.
@en
P2093
P304
P356
10.1210/MEND-5-11-1571
P577
1991-11-01T00:00:00Z